from Friday --
Clarification:
What I wrote Friday about vaccine manufacturers was in fact true -- but in the past. I am still researching this matter. But in the same issue of National Geographic (November 2017), a public-private partnership has been able to make available to countries such as Bangladesh vaccines for pneumococcal virus at a much-reduced cost. Thus while the history of the high cost of this particular vaccine remains, currently there has been significant improvement. I regret any impression left about current conditions.
Of course there continue to be many problems related to the profit motive in medicine, including needless deaths. We remain in a national and international emergency with ever so much work left to be done.
Clarification:
What I wrote Friday about vaccine manufacturers was in fact true -- but in the past. I am still researching this matter. But in the same issue of National Geographic (November 2017), a public-private partnership has been able to make available to countries such as Bangladesh vaccines for pneumococcal virus at a much-reduced cost. Thus while the history of the high cost of this particular vaccine remains, currently there has been significant improvement. I regret any impression left about current conditions.
Of course there continue to be many problems related to the profit motive in medicine, including needless deaths. We remain in a national and international emergency with ever so much work left to be done.
No comments:
Post a Comment
Thank you for your comment to "The Musical Patriot." Moderation is used on this blog to help prevent spam and other inappropriate messages. Please complete this form so your comment may be processed for possible inclusion on the blog. Thank you for being a reader of "The Musical Patriot!"